1st Feb 2007 07:00
Embargoed: 0700hrs, 1 February 2007
Akers Biosciences, Inc. (the "Company") Directors Share Purchase
The Company was informed yesterday that its Chief Executive Officer, Dr. Raymond Akers, purchased, on 31 January, 2007, 1,500,000 Ordinary Shares in the Company ("Ordinary Shares") at a price of 40 pence per Ordinary Share.
As a result of this share purchase, Dr Raymond Akers, and his immediate family, now hold 7,267,005 Ordinary Shares, representing approximately 12% of the issued share capital of the Company.
Enquiries:Dr. Ray Akers Chief Executive Officer, Akers Biosciences, 020 7917 9476 Inc. Paul Freedman 001 856 848 8698 Chief Financial Officer, Akers Biosciences, Inc. Ben Simons Hansard Group 020 7245 1100
AKERS BIOSCIENCES INCRelated Shares:
AKR.L